Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK8 | P45983 | 1/20 | 0.54 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.54 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.54 |
| ▸ | NMUR2 | Q9GZQ4 | 4/20 | 0.51 |
| ▸ | NMUR1 | Q9HB89 | 4/20 | 0.51 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.48 |
| ▸ | APLNR | P35414 | 1/20 | 0.48 |
| ▸ | BDKRB2 | P30411 | 1/20 | 0.47 |
| ▸ | ACE | P12821 | 3/20 | 0.47 |
| ▸ | ACE2 | Q9BYF1 | 3/20 | 0.47 |
| ▸ | F2 | P00734 | 2/20 | 0.47 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.46 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.46 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.46 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29506914 | 0.93 | MAPK8 (0.51) | MAPK8MAPK9MAPK10NMUR2NMUR1 | |
| SCHEMBL31490504 | 0.93 | MAPK8 (0.52) | MAPK8MAPK9MAPK10NMUR2NMUR1 | |
| SCHEMBL29506907 | 0.92 | SLC6A2 (0.53) | MAPK8MAPK9MAPK10NMUR2NMUR1 | |
| SCHEMBL29674936 | 0.91 | SLC6A2 (0.52) | MAPK8MAPK9MAPK10NMUR2NMUR1 | |
| SCHEMBL29506913 | 0.91 | MAPK8 (0.50) | MAPK8MAPK9MAPK10NMUR2NMUR1 | |
| SCHEMBL31049844 | 0.90 | MAPK8 (0.48) | MAPK8MAPK9MAPK10NMUR2NMUR1 | |
| SCHEMBL29726955 | 0.90 | SLC6A2 (0.55) | NMUR2NMUR1SLC6A2BDKRB2F2 | |
| SCHEMBL29601373 | 0.89 | MAPK8 (0.52) | MAPK8MAPK9MAPK10NMUR2NMUR1 | |
| SCHEMBL30856561 | 0.88 | MAPK8 (0.46) | MAPK8MAPK9MAPK10NMUR2NMUR1 | |
| SCHEMBL29506912 | 0.88 | MAPK8 (0.52) | MAPK8MAPK9MAPK10NMUR2NMUR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025082283-A1 | LIGAND COMPOUND OF CYCLOPEPTIDE STRUCTURE, NUCLIDE MARKER THEREOF, PHARMACEUTICAL COMPOSITION, AND USE | 四川科伦博泰生物医药股份有限公司 | 2025-04-24 | — | — | WO | disclosed |